DadFinStart your free week
DadFin › Stocks › Real Estate › UHT

Universal Health Realty Income Tru (UHT) stock score

Real Estate · REIT - Healthcare Facilities · United States

$37.57 ▲ +0.08% today

56.2
Dad Score, out of 100
middling

Universal Health Realty Income Tru (UHT) is a REIT - Healthcare Facilities company in the Real Estate sector, listed in the United States. On DadFin's weekly run it scores 56.2 out of 100 on the Dad Score, a middling reading that places the business ahead of 56% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Real Estate it ranks #92 of 240. Its strongest axes are valuation, quality and macro; its weakest are price action and conviction.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Above average
Quality
Strong
Growth
Average
Price action
Weak
Risk
Average
Conviction
Below average
Liquidity
Weak
Macro
Strong

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)26.9×
P/E (forward)0.0×
Dividend yield8.18%
Return on capital20.0%
Operating margin37.9%
Revenue growth (YoY)+0.2%
FCF yield5.6%
Net debt / EBITDA5.87×
Piotroski F-Score5 / 9
52-week change+6.3%
Market cap$509M
Next earningsOct 26, 2026

What subscribers see on UHT

Start your free weekSubscriber? Open the full research →

REIT - Healthcare Facilities peers

StockCompanyDad ScoreBandMarket cap
WELLWelltower Inc.46.6middling$164.1B
VTRVentas, Inc.41.7middling$43.1B
OHIOmega Healthcare Investors, Inc.77.0good$14.4B
DOCHealthpeak Properties, Inc.37.7weak$13.8B
AHRAmerican Healthcare REIT, Inc.51.5middling$11.1B
CTRECareTrust REIT, Inc.29.1weak$8.6B
SBRASabra Health Care REIT, Inc.35.0weak$4.9B
NHINational Health Investors, Inc.82.4good$3.2B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.